The big picture: Adecco Group is restructuring its operating model in its Q3 2026 results, consolidating professional recruitment and RPO from the LHH global business unit into Workforce Solutions alongside staffing, tech staffing, MSP and outsourcing. The move is designed to simplify the structure, improve delivery efficiency and strengthen commercial coordination. Why it matters: Staffing leaders should read this as a shift from brand-led silos toward a more integrated workforce-solutions model. It signals margin discipline, tighter commercial alignment and a push to make recruitment, staffing and outsourcing services work as one delivery engine. Between the lines: - The plan targets €75 million of additional run-rate savings by Q3 2027, incremental to €200 million in annualized savings achieved over the past three years. - Adecco, LHH and Akkodis remain core go-to-market brands, alongside existing specialist global and local brands. - From January 2027, Ian Lee becomes President Workforce Solutions and Christophe Catoir becomes Chief Innovation and Business Development Officer; both continue to report to CEO Denis Machuel. Staffing & HR impact: Recruiter mobility and account ownership are likely to shift as RPO and professional recruitment move from LHH into Workforce Solutions, changing how talent teams are staffed, managed and measured. The restructuring is aimed at profitable growth and margin expansion rather than headcount reduction alone, but delivery efficiency gains will depend on clean handovers, commercial coordination and retention of key recruiters and account leads. The bottom line: Watch Q3 2027 savings delivery and the January 2027 leadership transition as proof that Adecco can turn brand consolidation into durable margin expansion.
The big picture: DDi (Drug Development informatics) has been honored as the 'Best Global Regulatory & Clinical Development Partner 2025' by Global Health & Pharma (GHP) for its innovative solutions in the life sciences industry. This award highlights DDi's commitment to streamlining regulatory workflows and accelerating clinical development worldwide. Why it matters: This recognition underscores the increasing demand for specialized technology and expertise in navigating complex global regulatory landscapes, impacting talent needs and operational efficiency for life sciences organizations. Between the lines: - DDi provides regulatory and clinical solutions, including intelligence, trial management, and data integration. - The award acknowledges DDi's focus on innovation, compliance, and customer-centric approaches. - DDi is a privately owned company with global offices in the USA, UK, India, and Singapore. Staffing & HR impact: The demand for specialized talent in regulatory affairs and clinical development informatics will likely increase, driving competition for skilled professionals and potentially impacting recruiter mobility and compensation in the life sciences sector. Companies like DDi will need robust talent acquisition strategies to support their expanding global footprint and technological capabilities. The bottom line: DDi's award signals a growing emphasis on technological solutions and expert partnerships to manage the intricate regulatory and clinical development processes in the global health sector.